Table of Content



Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Antibiotics Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. List of Key End-users, by region / by product / by country
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & Compliances
3.7. Market Dynamics
3.7.1. Market Driver Analysis
3.7.2. Development of advanced products
3.7.3. Increasing prevalence of` infectious diseases
3.7.4. Rising collaborative development efforts
3.7.5. Market Restraint Analysis
3.7.6. Uncertain regulatory policies
3.7.7. High R & D cost
3.7.8. Development of resistance against antibiotics
3.7.9. Industry Challenges
3.7.10. Increasing resistance to antibiotics.
3.8. Antibiotics: Market Analysis Tools
3.8.1. Industry Analysis - Porter’s
3.8.1.1. Supplier Power: (Low)
3.8.1.2. Buyer Power: (Moderate)
3.8.1.3. Substitution Threat: (Moderate)
3.8.1.4. Threat from new entrant: (Moderate)
3.8.1.5. Competitive rivalry: (High)
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4. Market Entry Strategies
Chapter 4. Antibiotics Market: Segment Analysis, By Action Mechanism, 2015 - 2026 (USD Million)
4.1. Definitions & Scope
4.2. Action mechanism market share analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Antibiotics Market, by Action Mechanism, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Cell Wall Synthesis Inhibitors
4.5.2. Protein Synthesis Inhibitors
4.5.3. DNA Synthesis Inhibitors
4.5.4. RNA Synthesis Inhibitors
4.5.5. Mycolic Acid Inhibitors
Chapter 5. Antibiotics Market: Segment Analysis, By Drug Class, 2015 - 2026 (USD Million)
5.1. Definitions & Scope
5.2. Action mechanism market share analysis, 2018 & 2026
5.3. Segment Dashboard
5.4. Global Antibiotics Market, by Drug Class, 2015 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
5.5.1. Cephalosporin
5.5.2. Penicillin
5.5.3. Fluoroquinolones
5.5.4. Macrolides
5.5.5. Carbapenem
5.5.6. Aminoglycosides
5.5.7. Sulfonamides
5.5.8. Other
Chapter 6. Antibiotics Market: Regional Market Analysis, 2015 - 2026 (USD Million)
6.1. Definitions & Scope
6.2. Regional market share analysis, 2018 & 2026
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
6.5. Regional Market Share and Leading Players, 2018
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East & Africa
6.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
6.6.1. North America
6.6.2. Europe
6.6.3. Asia Pacific
6.6.4. Latin America
6.6.5. Middle East & Africa
6.7. Market Size, & Forecasts, and Trend Analysis, 2018 to 2025:
6.8. North America
6.8.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
6.8.2. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.8.3. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.8.4. U.S.
6.8.4.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.8.4.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.8.5. Canada
6.8.5.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.8.5.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.9. Europe
6.9.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
6.9.2. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.9.3. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.9.4. Germany
6.9.4.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.9.4.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.9.5. U.K.
6.9.5.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.9.5.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.9.6. France
6.9.6.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.9.6.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.9.7. Italy
6.9.7.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.9.7.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.9.8. Spain
6.9.8.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.9.8.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.10. Asia Pacific
6.10.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
6.10.1.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.10.1.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.10.2. China
6.10.2.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.10.2.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.10.3. Japan
6.10.3.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.10.3.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.10.4. India
6.10.4.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.10.4.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.10.5. Thailand
6.10.5.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.10.5.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.10.6. South Korea
6.10.6.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.10.6.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.11. Latin America
6.11.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
6.11.2. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.11.3. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.11.4. Brazil
6.11.4.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.11.4.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.11.5. Mexico
6.11.5.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.11.5.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.11.6. Argentina
6.11.6.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.11.6.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.11.7. Columbia
6.11.7.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.11.7.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.12. Middle East and Africa
6.12.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
6.12.2. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.12.3. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.12.4. South Africa
6.12.4.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.12.4.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.12.5. Saudi Arabia
6.12.5.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.12.5.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
6.12.6. UAE
6.12.6.1. Market estimates and forecast, by action mechanism, 2015 - 2026 (USD Million)
6.12.6.2. Market estimates and forecast, by drug class, 2015 - 2026 (USD Million)
Chapter 7. Antibiotics Market - Competitive Analysis
7.1. Recent developments & impact analysis, by key market participants
7.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2018
7.4. Public Companies
7.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
7.4.2. Company Market Share/Ranking, by region
7.4.3. Competitive Dashboard Analysis
7.4.3.1. Market Differentiators
7.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
7.5. Private Companies
7.5.1. List of key emerging companies’ /technology disruptors/innovators
7.5.2. Funding Outlook (Optional)
7.5.3. Regional network map
7.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
7.6. Supplier Ranking
7.7. Key companies profiled
7.7.1. Pfizer, Inc.
7.7.1.1. Company Overview
7.7.1.2. Financial Performance
7.7.1.3. Product Benchmarking
7.7.1.4. Strategic Initiatives
7.7.2. Janssen Pharmaceuticals.
7.7.2.1. Company Overview
7.7.2.2. Financial Performance
7.7.2.3. Product Benchmarking
7.7.2.4. Strategic Initiatives
7.7.3. Abbott
7.7.3.1. Company Overview
7.7.3.2. Financial Performance
7.7.3.3. Product Benchmarking
7.7.3.4. Strategic Initiatives
7.7.4. GlaxoSmithKline plc.
7.7.4.1. Company Overview
7.7.4.2. Financial Performance
7.7.4.3. Product Benchmarking
7.7.4.4. Strategic Initiatives
7.7.5. Sanofi.
7.7.5.1. Company Overview
7.7.5.2. Financial Performance
7.7.5.3. Product Benchmarking
7.7.5.4. Strategic Initiatives
7.7.6. Novartis AG.
7.7.6.1. Company Overview
7.7.6.2. Financial Performance
7.7.6.3. Product Benchmarking
7.7.6.4. Strategic Initiatives
7.7.7. Bayer AG.
7.7.7.1. Company Overview
7.7.7.2. Financial Performance
7.7.7.3. Product Benchmarking
7.7.7.4. Strategic Initiatives
7.7.8. Bristol-Myers Squibb Company.
7.7.8.1. Company Overview
7.7.8.2. Financial Performance
7.7.8.3. Product Benchmarking
7.7.8.4. Strategic Initiatives
7.7.9. Eli Lilly and Company.
7.7.9.1. Company Overview
7.7.9.2. Financial Performance
7.7.9.3. Product Benchmarking
7.7.9.4. Strategic Initiatives
7.7.10. Astellas Pharma, Inc.
7.7.10.1. Company Overview
7.7.10.2. Financial Performance
7.7.10.3. Product Benchmarking
7.7.10.4. Strategic Initiatives
Chapter 8. KOL Commentary
Chapter 9. Recommendations



List of Figures



FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary, USD Million
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Antibiotics market mechanism outlook key takeaways
FIG. 16 Antibiotics market: Mechanism movement analysis
FIG. 17 Cell wall synthesis inhibitors market, 2015 - 2026 (USD Million)
FIG. 18 Protein synthesis inhibitors market, 2015 - 2026 (USD Million)
FIG. 19 DNA synthesis inhibitors market, 2015 - 2026 (USD Million)
FIG. 20 RNA synthesis inhibitors market, 2015 - 2026 (USD Million)
FIG. 21 Mycolic acid inhibitors market, 2015 - 2026 (USD Million)
FIG. 22 Folic acid synthesis inhibitors market, 2015 - 2026 (USD Million)
FIG. 23 Antibiotics market drug class outlook key takeaways
FIG. 24 Antibiotics market: Drug class movement analysis
FIG. 25 Cephalosporins market, 2015 - 2026 (USD Million)
FIG. 26 Penicillin market, 2015 - 2026 (USD Million)
FIG. 27 Fluoroquinolones market, 2015 - 2026 (USD Million)
FIG. 28 Macrolides market, 2015 - 2026 (USD Million)
FIG. 29 Carbapenems market, 2015 - 2026 (USD Million)
FIG. 30 Aminoglycosides market, 2015 - 2026 (USD Million)
FIG. 31 Sulfonamides market, 2015 - 2026 (USD Million)
FIG. 32 Other antibiotics market, 2015 - 2026 (USD Million)
FIG. 33 Regional market place: Key takeaways
FIG. 34 Regional outlook, 2018 & 2026
FIG. 35 North America antibiotics market, 2015 - 2026 (USD Million)
FIG. 36 U.S. antibiotics market, 2015 - 2026 (USD Million)
FIG. 37 Canada antibiotics market, 2015 - 2026 (USD Million)
FIG. 38 Europe antibiotics market, 2015 - 2026 (USD Million)
FIG. 39 U.K. antibiotics market, 2015 - 2026 (USD Million)
FIG. 40 Germany antibiotics market, 2015 - 2026 (USD Million)
FIG. 41 France antibiotics market, 2015 - 2026 (USD Million)
FIG. 42 Spain antibiotics market, 2015 - 2026 (USD Million)
FIG. 43 Italy antibiotics market, 2015 - 2026 (USD Million)
FIG. 44 Asia Pacific antibiotics market, 2015 - 2026 (USD Million)
FIG. 45 Japan antibiotics market, 2015 - 2026 (USD Million)
FIG. 46 China antibiotics market, 2015 - 2026 (USD Million)
FIG. 47 India antibiotics market, 2015 - 2026 (USD Million)
FIG. 48 Thailand antibiotics market, 2015 - 2026 (USD Million)
FIG. 49 South Korea antibiotics market, 2015 - 2026 (USD Million)
FIG. 50 Latin America antibiotics market, 2015 - 2026 (USD Million)
FIG. 51 Brazil antibiotics market, 2015 - 2026 (USD Million)
FIG. 52 Mexico antibiotics market, 2015 - 2026 (USD Million)
FIG. 53 Argentina antibiotics market, 2015 - 2026 (USD Million)
FIG. 54 Columbia antibiotics market, 2015 - 2026 (USD Million)
FIG. 55 MEA antibiotics market, 2015 - 2026 (USD Million)
FIG. 56 South Africa antibiotics market, 2015 - 2026 (USD Million)
FIG. 57 Saudi Arabia antibiotics market, 2015 - 2026 (USD Million)
FIG. 58 UAE antibiotics market, 2015 - 2026 (USD Million)
FIG. 59 Strategy framework


List of Tables



TABLE 1 Antibiotic drugs under Phase III clinical trial, 2015
TABLE 2 Public-private and Private-private agreements:
TABLE 3 North America antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 4 North America antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 5 U.S. antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 6 U.S. antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 7 Canada antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 8 Canada antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 9 Europe antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 10 Europe antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 11 U.K. antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 12 U.K. antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 13 France antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 14 France antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 15 Italy antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 16 Italy antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 17 Spain antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 18 Spain antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 19 Germany antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 20 Germany antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 21 Asia Pacific antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 22 Asia Pacific antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 23 Japan antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 24 Japan antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 25 China antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 26 China antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 27 India antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 28 India antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 29 Thailand antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 30 Thailand antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 31 South Korea antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 32 South Korea antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 33 Latin America antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 34 Latin America antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 35 Brazil antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 36 Brazil antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 37 Brazil antibiotics market forecasts, by drug class, 2016 - 2026 (USD Million)
TABLE 38 Mexico antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 39 Mexico antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 40 Argentina antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 41 Argentina antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 42 Columbia antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 43 Columbia antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 44 MEA antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 45 MEA antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 46 South Africa antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 47 South Africa antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 48 Saudi Arabia antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 49 Saudi Arabia antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)
TABLE 50 UAE antibiotics market estimates, by mechanism, 2015 - 2026 (USD Million)
TABLE 51 UAE antibiotics market estimates, by drug class, 2015 - 2026 (USD Million)